Summary: During cerebral ischemia blood-brain barrier (BBB) disruption is a critical event leading to vasogenic edema and secondary brain injury. Gelatinases A and B are matrix metalloproteinases (MMP) able to open the BBB, The current study analyzes by zymography the early gelatinases expression and activation during permanent ischemia in mice (n = 15).
of activated MMP-9, we detected by the Evan's blue extrava sation method a clear increase of BBB permeability, Tissue inhibitor of metalloproteinase-1 was not modified during per manent ischemia at any time. The ProMMP-2 was significantly (P < 0.05) increased only after 24 hours of permanent ischemia (mean 213.2 AU, SD ± 60.6 versus mean 94.6 AU, SD ± 13.3), and no activated form was observed. The appearance of acti vated MMP-9 after 4 hours of ischemia in correlation with BBB permeability alterations suggests that MMP-9 may play an active role in early vasogenic edema development after stroke. Key Words: Metalloproteinases-Brain-Ischemia Vasogenic edema-Mice.
laminin, various proteoglycans, and heparan sulfates (Yurchenco and Schittny, 1990) , Metalloproteinases (MMP) are proteolytic enzymes (Zn 2 + -endopeptidases) secreted as zymogen, which must be cleaved to be fully active. They are involved in the remodeling of the ex tracellular matrix in a variety of physiologic and patho physiologic conditions. Among MMP, gelatinase A (MMP-2) and gelatinase B (MMP-9), also known as type IV collagenases, are able to digest the endothelial basal lamina leading to the opening of the BBB (Rosenberg et aI., 1992 (Rosenberg et aI., , 1996a (Rosenberg et aI., ,b, 1998 . Inhibition of MMP reduces brain capillary damage in mice with experimental auto immune encephalomyelitis (Gijbels et aI., 1994) . During cerebral ischemia-reperfusion, endothelial basal lamina dissolution starts as soon as 2 hours after initiation of ischemia and continues during reperfusion (Hamann et aI., 1995) , leading to a potentially harmful accumulation of leukocytes in tissue (Chen et aI., 1992) . Increased BBB permeability can be detected a few hours after the ischemic insult (Belayev et aI., 1996; Kondo et aI., 1997; Rosenberg et aI., 1998) . Expression of MMP-9 and MMP-2 has been shown to be significantly increased during stroke in human (Anthony et al., 1997) and rat models of focal ischemia (Romanic et ai., 1998; Rosen berg et ai., 1996b; Rosenberg et ai., 1998) . In the animal studies, MMP-9 increase was significant only after 12 hours after ischemia, revealing a discrepancy between MMP induction and the first signs of BBB alterations reported to occur earlier (Hamann et ai., 1995 ; Rosen berg et a!., ] 998). Recent experimental data show that inhibition of MMP can reduce the degree of brain infarc tion produced by permanent focal ischemia (Romanic et ai., 1998) and can decrease the BBB opening after 3 hours of reperfusion following 2 hours of focal ischemia (Rosenberg et a!., 1998) . These results imply that MMP play a critical role in brain injury after stroke. But so far no study has reported the early induction and activation of latent MMP-9 or MMP-2 after ischemia. Our study evaluates the effect of ischemia on the early expression and activation of gelatinases in permanent middle cere bral artery occlusion (pMCAO) using a recently de scribed in vivo method of MMP extraction (Zhang and Gottschall, 1997) . We also determined if MMP expres sion was correlated with BBB permeability alterations in mice after focal stroke.
MATERIALS AND METHODS

Focal cereb�al ischemia in mice
Adult male CD-I mice (35 to 40 g) were subjected to per manent focal ischemia by intraluminal middle cerebral artery blockade with a nylon suture, as described by others . The mice (n = 15) were anesthetized with 2.0% isoflurane in 30% oxygen and 70% nitrous oxide using a face mask. Central temperature was maintained at 37°C with a homeothermic blanket. Cannulation of a femoral artery allowed the monitoring of blood pressure and arterial blood gases, with samples for analysis being taken immediately after cannulation and 10 minutes after occlusion. Following the midline skin incision, the left external carotid artery was exposed, and its branches were electrocoagulated. An II.O-mm 5-0 surgical monofilament nylon suture, blunted at the end, was introduced into the left internal carotid artery through the external carotid artery stump and tightly fixed at the appropriate position at the end of surgery.
Metalloproteinase extraction
Metalloproteinase extraction from brains was performed ac cording to a previously described method (Zhang and Gottschall, 1997) . All procedures were performed on ice. Brain tissues were homogenized with 2-mL Teflon glass homogeniz ers in a lysis buffer (50 mmollL Tris-HCI pH 7.6, 150 mmollL NaC!, 5 mmol/L CaCI2, 0.05% BRU-35, 0.02% NaN3, 1%
Triton X-laO). Ten-microliter aliquots of the homogenates were saved for total protein measurements (BCA kit, Pierce, Rockford, IL, U.S.A.). Homogenates were centrifuged at 12,000 x g for 5 minutes. The supernatants were recovered and incubated for 60 minutes with gelatin-sepharose 4B (Pharmacia Biotech AB, Uppsala, Sweden) with constant shaking. After incubation, samples were centrifuged at 500 x g for 2 minutes.
Pellets were washed with a buffer containing 50 mmollL Tris HCI pH 7.6, 150 mmollL NaCI, 5 mmol/L CaCI2, 0.05% BRU-35, and 0.02% NaN3. After a second centrifugation, the pellets were resuspended in 150 fLL of elution buffer (50 mmollL Tris-HCl pH 7.6, 150 mmol/L NaC!, 5 mmollL CaCI2, 0.05% BRIJ-35, 0.02% NaN" dimethylsulfoxide 10%) for 30 minutes.
The MMP activity of the eluates was measured by gelatin zy mography.
Standard zymography
Zymographies were performed using a published method (Kleiner and Stetler-Stevenson, 1994) 
Reverse zymography
Reverse zymographies were performed using a published method (Oliver et a!., 1997 ) with a few modifications. Ten microliters of nonreducing sample buffer (0.4 mollL Tris pH 6.8, 5% SDS, 20% glycerol, 0.05% bromophenol blue) were added to the samples. Samples then were loaded onto 15% SDS-PAGE gels in which 2.2 mg/mL porcine skin gelatin (Sigma), and 150 ng/mL of proMMP-9 were copolymerized.
Gels were run at 40 rnA for 3 hours. After migration, gels were incubated with 2.5% Triton-X 100 twice for 1 hour at room temperature, washed for 10 minutes in TNCA (50 mmollL Tris pH 7.5, 200 mmollL NaCl, 5 mmollL CaCI2), and further in cubated for 16 hours in TNCA in a water bath at 37°C. Gels were stained for 30 minutes in coomassie blue (1 % coomassie brilliant blue, 30% methanol, 10% acetic acid) and destained in 30% methanolll 0% acetic acid four times for 5, 15, 45, and 60 minutes, respectively. Tissue inhibitor of metalloproteinase-I (TIMP-I; Oncogen Research) was identified as a 28-kd blue band. Twenty microliters of TIMP-l were loaded as standard.
Bands were scanned using a densitometer (GS-700; Bio-Rad).
Immunohistochemistry
Anesthetized animals were perfused with 10 U/mL heparin and subsequently with 4% formaldehyde in 0.1 mollL phos phate-buffered saline (PBS) (pH 7.4) at 4 and 24 hours after permanent ischemia, respectively. Brains were removed, post fixed for 36 hours in 4% formaldehyde, sectioned at 50 f.Lm on a vibratome, and processed for immunohistochemical study.
The sections were incubated with blocking solution containing 20% normal goat serum (Vector, Burlingame, CA, U.S.A.) and reacted with rabbit anti-human MMP-9 polyclonal antibody (Anawa, Wangen, Switzerland) at a dilution of I :50. Immuno histochemical study was performed using the avidin-biotin technique (Vector), and then the nuclei were counterstained with methyl green solution for 10 minutes. As a negative con trol, sections were incubated without primary antibodies. For histologic assessment, alternate slices from each brain section were stained with cresyl violet. 
Western blot
Evans blue extravasation
Five minutes before pMCAO, 0.1 mL 4% of Evans blue in saline was injected in the jugular vein. Animals were perfused with 10 U/mL heparin and subsequently with 4% formaldehyde in 0.1 mollL PBS (pH 7.4) at 2, 4, and 6 hours after permanent ischemia, respectively. Brains were removed, postfixed for 24 hours in 4% formaldehyde, and sectioned on a vibratome. Sec tions were dried at room temperature in a dark box, stained with 2.5 x 0.1 mg/mL Hoechst 33258 (Molecular Probes, Eugene, OR, U.S.A.) for nuclear staining and mounted. The BBB break down was assessed by fluoromicroscopic detection of Evans blue extravasation.
Statistical analysis
Results of MMP activities are expressed as mean ± SD.
Comparisons between multiple groups were performed using an analysis of variance (BonferroniiDunn t test), whereas com parisons between two groups were achieved using the Student's t test. P < 0.05 was considered statistically significant. 
RESULTS
Physiologic data and cerebral infarction
Physiologic parameters showed no significant differ ences in MABP, body temperature, and arterial blood gas analyses between each time point. The preischemic physiologic variables (mean ± SD) were as follows; MABP (mm Hg) 73 ± 5.6; body temperature (0C) 36.5 ± 0. 1; Pao2 (mm Hg) 133. 1 ± 32.8; Pco2 26.4 (± 6.4); pH 7.37 (± 0.04). By cresyl violet staining, an ischemic le sion was visible as a pale, slightly stained area in the ischemic hemisphere as early as 2 hours after ischemia, which further enlarged at 4 and 24 hours after ischemia, respectively. The time-dependent increase of infarction in mouse brain using the intraluminal suture blockade was consistent with previous reports that used the same focal stroke model in mice (Kondo et aI., 1997) . Infarc tion volumes at 1 day after permanent ischemia also were similar to our previous report (Yang et aI., 1994) .
Gelatinases and TIMP-l expression
Latent (proMMP) and activated forms (MMP) were measured using the technique of zymography, in which proMMP-9 and MMP-9 appeared as light bands on a blue background with molecular weights of 96 and 88 kd, respectively, whereas proMMP-2 was identified at 72 kd. As our cleaved form of MMP-9 was higher than usually reported (84 kd), we incubated several extracted samples from nonischemic regions (showing no band at 88 kd) with 1 mmolfL p-aminophenylmercuric acetate known to activate MMP. The zymography performed on these artificially activated samples and the corresponding samples from ischemic regions (genuinely showing the 88-kd band) showed similar bands at 88 kd in treated and nontreated samples (data not shown), allowing us to as sume that the cleaved form observed in ischemic samples was the regular cleaved form of MMP-9.
Low levels of proMMP-9 and proMMP-2 were de tected in the contralateral corresponding brain region of mice subjected to pMCAO and in normal brains (Fig.  IA) . No modification of MMP levels was observed over time in the contralateral control regions. During pM CAO, a strong increase of the proMMP-9 level was ob served in the ischemic regions as soon as 2 hours after occlusion (Fig. 1A) . This increase of proMMP-9 already was maximal at 2 hours and persisted at similar levels after 4 and 24 hours of ischemia, respectively (Fig. IA) . Although no band corresponding to the activated form of MMP-9 was observed in either normal brains or in con tralateral regions, activation of MMP-9 was first ob served at 4 hours of ischemia and increased at 24 hours (Fig. IA) . On the other hand, proMMP-2 was mildly induced by permanent ischemia; indeed, only 24 hours of ischemia significantly increased the enzyme level (Fig.  I A) . No activated form of MMP-2 could be found at any ACTIVATED MMP-9 AND FOCAL CEREBRAL ISCHEMIA Table 1 .
To further evaluate the actual proteolytic activity of our extracted samples, we performed a type IV collage nase activity assay, which showed a significant increase of collagenolytic activity in samples taken from brains of mice subjected to 4 hours of ischemia (Fig. IB) . This activity was inhibited by EDTA, confirming the involve ment of MMP. Since no active MMP-2 was observed on our zymographies, we can assume that the digestion of type IV collagen revealed in the assay resulted from MMP-9. We finally evaluated the balance between the expres sion of MMP-9 and its natural inhibitor, TIMP-I, which was measured using the technique of reverse zymogra phy. The inhibitor was spontaneously expressed in con tralateral regions, and no modification of TIMP-I could be found after permanent ischemia (Fig. 2) .
Regional MMP-9 expression also was analyzed by im munohistochemical study (Fig. 3) . Whereas MMP-9 was Mean values (±SD) of optical densities representing gelatinolytic activities of MMP-9 and MMP-2 found in control samples (normal brains or contralateral corresponding regions) and ischemic regions (MCA territory).
Values are compared using analysis of variance (Bonferroni/Dunn I-test). ProMMP-9 activity was significantly higher after 2, 4, and 24 hours of permanent ischemia than in control samples (* P < 0.00 I). ProMMP-2 was significantly increased after 24 hours of permanent ischemia (t P < 0.05) as compared to controls. MMP metalloproteinases; MMP-2 gelatinase A; MMP-9, gelatinase B; pMCAO, permanent middle cerebral artery occlusion. weakly but diffusely (cortex and caudate putamen) de tectable in control samples (Fig. 3A) , a strong immuno reactivity was observed during pMCAO at 4 and 24 hours of ischemia, respectively, which had a regional predominance at the inner boundary of the ischemic cor tex (Fig. 3B and D) . There was a mild expression of MMP-9 at the middle cerebral artery territory cortex (Fig. 3C) and no expression at the caudate putamen (Fig. 3E) . There was no immunoreactivity in the control specimens, which were treated without primary antibody (Fig. 3F) . Table 2 summarizes the regional distribution of (pro )MMP-9 observed by immunohistochemical study. By Western blot analysis (Fig. 4) , proMMP-9 im munoreactivity was evident as a characteristic band of molecular mass 96 kd from both the nonischemic control and from the sample after 4 and 24 hours MCAO, re spectively. On the contrary, the activated form of MMP-9 wai'j: not recognized in nonischemic controls but was significantly increased after 4 and 24 hours of isch emia, respectively. These data confirm the reactivity of the antibody to mice MMP-9 used in this study, and that the activated form of MMP-9 increased after focal cere bral ischemia.
Vasogenic edema detection
Blood-brain barrier permeability was evaluated in ischemic regions and in contralateral regions at 2, 4, and 6 hours of ischemia, respectively. Evans blue leakage was first detected in ischemic regions after 4 hours of occlusion (Fig. SD) ; this extravasation was confirmed at 6 hours (Fig. SF) . Evans blue extravasation was detected in the ischemic cortex and in the ischemic caudate putamen. In ischemic regions after 2 hours of ischemia and in contralateral regions at each time point of isch emia, the fluorescent dye was detected only in the vessels as shown in Figs. SA to SC and SE.
DISCUSSION
This study shows for the first time that 2 hours of permanent focal ischemia in mice induce a significant (P < 0.00 1) and strong increase of proMMP-9 expression. On the other hand, the activated form of MMP-9, which plays the actual pathophysiologic role in BBB alteration, is induced 4 hours after the onset of ischemia. Previous studies performed using a model of pMCAO in rats have shown that proMMP-9 and, possibly, activated MMP-9 are significantly increased only after 12 hours of isch-J Cereb Blood Flow Metab, VoL 19, No, 9, 1999 emia (Romanic et ai., 1998; Rosenberg et ai., 1998; Rosenberg et ai., 1996b) . In those studies, no proMMP-9 was observed in control samples, whereas proMMP-2 was constitutively expressed. Similar results were ob tained after transient MCAO (tMCAO) in rats (Rosen berg et ai., 1998). In our study, not only proMMP-2 but also proMMP-9 were detected in normal mice brains, and their levels were similar to those detected in the contralateral (control) regions sampled from mice sub jected to pMCAO. The apparent discrepancies between our results and those of previous studies can be explained by technical differences. We used a recently described in vivo method of MMP purification (Zhang and Gottschall, 1997) , which allowed us to substantially increase the threshold of MMP-9 detection, as suggested by the fact that we already detected the proform of MMP-9 in con trol samples. Nevertheless, since previous studies were performed on spontaneously hypertensive rats, we can not exclude that the differences observed are related to the animal species.
The appearance of the activated form of MMP-9 after a few hours of ischemia in the current study was accom panied by a clear alteration of BBB permeability (Fig. S) . These results of BBB alteration are consistent with re cent data showing that vasogenic edema can be detected after 4 hours of focal ischemia-reperfusion in rats (Rosenberg et ai., 1998; Belayev et ai., 1996) and 2 to 8 hours after tMCAO in mice (Kondo et ai., 1997) . Nev ertheless, the increase of MMP-9 during permanent isch emia, together with the appearance of a clear leakage of the BBB observed in our model, occur earlier than in a previous report, showing that BBB impermeability was preserved after 6 hours of ischemia, whereas a clear breakdown of the BBB (measured by labelled amino isobutyric acid) was observed after an equal period of ischemia-reperfusion (Yang and Betz, 1994) . Although the aggravation of edema by reperfusion of damaged vessels cannot be questioned, caution should be used when comparing BBB permeability modifications in duced by pMCAO and tMCAO using intravenous trac ers. Indeed, evaluation of BBB leakage during pMCAO with tracers reaching poorly nonperfused regions could underestimate the actual BBB damage. In our study, to solve this problem, we injected the Evans blue dye shortly before pMCAO. This technical procedure al lowed us to detect BBB permeability alterations as early as 4 hours after the onset of ischemia, On the other hand, the examination of Evans blue extravasation by fluoro microscopic study increased the sensitivity of the method, as illustrated by the fact that extravasation was hardly detectable by standard microscopic examination (data not shown).
The etiology of the early BBB disruption in ischemia still is not clear, although endothelial dysfunction or de struction and factors like bradykinin and histamine have ACTIVATED MMP-9 AND FOCAL CEREBRAL ISCHEMIA with the anti-human MMP-9 antibody in the different ischemic regions after 4 and 24 hours of permanent ischemia, respectively, as summarized in Table 2 . (A) Representative control sample taken from cortex (similar immunoreactivity was found in caudate putamen).
(8) The inner boundary of ischemic cortex after 4 hours of ischemia. (C) The middle cerebral artery territory cortex after 24 hours of ischemia. (0) The inner boundary of ischemic cortex after 24 hours of ischemia. (E) The ischemic caudate putamen after 24 hours of ischemia. (F) Absence of immunoreactivity in specimens that were processed without primary antibody.
been implicated (Wahl et aI., 1988) . The current study brings more evidence that activated MMP might play an active role in the early and prolonged alteration of the BBB. The confirmation of this hypothesis could imply new therapeutic possibilities using natural or synthetic inhibitors of MMP. The exact mechanisms involved in MMP expression and activation during ischemia are not well defined. Early inducibility of proMMP-9 by ischemia observed in this study is not surprising according to the gene struc ture, which comprises an AP-l site in its promoter re gion. Early genes such as c-fos and c-jun, which are able to interact with the AP-l site and induce later gene ex pression, have been shown to be expressed at the mRNA Summary of (pro)MMP-9 expression detected by immunohisto chemistry. Analysis of enzyme distribution in brain ischemic and non ischemic regions of mice subjected to pMCAO. Control, contralateral corresponding region; pMCAO 4 h, 4 hours of permanent ischemia; pMCAO 24 h, 24 hours of permanent ischemia; -, no immunoreactivity to (pro)MMP-9; -(+), very mild immunoreactivity to (pro)MMP-9; +, mild immunoreactivity to (pro)MMP-9; ++, strong immunoreactivity to (pro)MMP-9; +++, very strong immunoreactivity to (pro)MMP-9. MCA, middle cerebral artery; MMP, metalloproteinase; MMP-9, gelatinase B; pMCAO, permanent middle cerebral artery occlusion.
level as soon as 30 minutes after ischemia (Welsh et aI., 1992) . Reactive oxygen species (ROS) burst brought with reoxygenation in previously ischemic regions has been invoked to explain BBB breakdown occurring at the time of reperfusion (Traystman et aI., 199 1) . But oxygen free radicals also are significantly induced during ischemia before effective reperfusion. Sustained ROS production has indeed been detected during pMCAO (Peters et a\., 1998) . Moreover, studies conducted in our laboratory have demonstrated the key pathophysiologic role played by ROS during brain ischemia (Chan et aI., 1996; Kondo et aI., 1997; Murakami et aI., 1997 Murakami et aI., , 1998 . The extent of hemispheric enlargement and infarct vol ume after pMCAO is markedly increased in manganese superoxide dismutase knockout mice compared with wild-type animals (Murakami et aI., 1998) , suggesting that ROS play a major role after pMCAO and tMCAO. In our study, MMP-9 expression analyzed by immuno histochemical study during pMCAO was clearly prepon derant in regions still supplied with some perfusion (in ner boundary of ischemic cortex), although it was absent in the ischemic core, suggesting a possible role of oxy gen free radicals in MMP-9 gene induction. Since in vitro MMP activation was reported to be closely related to ROS (Weiss et aI., 1985) and in vivo Evans blue extravasation in copper superoxide dis mutase knockout mice was shown to occur as early as 2 hours after focal ischemia (Kondo et aI., 1997) , it would be of great in terest to evaluate if MMP-9 induction/activation is af fected in superoxide dismutase-deficient mice. These studies are currently being undertaken in our laboratory.
Pro-gelatinase B also appears to be under the control of proinflammatory cytokines. Indeed, elevated levels of proMMP-9 have been detected in the CSF of patients with multiple sclerosis (Gijbels et aI., 1992) . More over, both MMP protein activity and mRNA levels are increased in rats with experimental autoimmune en cephalomyelitis (Pagenstecher et aI., 1998 proMMP-9 can be induced by tumor necrosis factor alpha in various cell types such as astrocytes (Gottschall et aI., 1995) , microglial cells (Gottschall and Deb, 1996) and fibroblasts (Hanemaaijer et aI., 1993) . Because of its earliness, induction of proMMP-9 at 2 hours observed in our model of focal ischemia probably cannot be attrib uted to tumor necrosis factor, which is produced mainly by leukocytes (monocytes) known to infiltrate infarcted areas later during reperfusion. However, it is interesting that tumor necrosis factor mRNA induction can be de tected in neurons as early as 3 hours after the initiation of permanent ischemia (Liu et aI., 1994) .
The mechanism of MMP activation consists in the cleavage of a propeptide. The result of this cleavage is a shorter protein, which is enzymatically active although the proform is not. The zymographic detection of acti vated (cleaved) forms of MMP, although indicative, does not reveal the actual proteolytic activity of the enzymes. The presence of active forms of type IV collagenases (MMP-9 or MMP-2) in our samples obtained from brains after 4 hours of ischemia could be confirmed by demon strating a significant increase of type IV collagenolytic activity (inhibited by EDTA) in those samples. These results, together with our zymographic data showing no cleaved form of MMP-2, strongly suggest that the col lagenolytic activity observed results from the activated form of MMP-9. Activation of MMP is a complex pro cess that is tightly regulated by their natural inhibitors, TIMP. During the zymographic procedure, MMP are separated from their respective TIMP. To partially solve this problem and better define the balance existing be tween MMP-9 and its natural inhibitor TIMP-l, we mea sured the activity of the latter by reverse zymography under the same experimental conditions. Contrary to MMP-9, TIMP-l was not induced during the first 24 hours by permanent ischemia. These results confirm im munohistologic findings published by others (Romanic et aI., 1998) showing a mild and diffuse expression of TIMP-l in ischemic regions and in nonischemic contra lateral controls. Nevertheless, a recent study showed a significant increase of TIMP-I mRNA after permanent and transient ischemia (Wang et aI., 1998) . This discrep ancy between mRNA and protein expression suggests a possible posttranscriptional regulation of the inhibitor. In conclusion, our study shows for the first time that proMMP-9 expression is significantly induced as soon as 2 hours after the onset of ischemia and that permanent ischemia triggers early proMMP-9 activation. The timing of proMMP-9 induction and activation correlated with the timing of BBB breakdown. These results are com pletely in accordance with those showing that the inhi bition of MMP diminishes the early opening of BBB after focal ischemia (Rosenberg et aI., 1998) .
